Medicare Enrolled

Dr. Vedashree Panthulu, M.D.

Rheumatology · Sun City Center, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
938 CYPRESS VILLAGE BLVD STE A, Sun City Center, FL 33573
8133335080
In practice since 2009 (16 years)
NPI: 1750510723 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Panthulu from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Panthulu? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Panthulu

Dr. Vedashree Panthulu is a rheumatology in Sun City Center, FL, with 16 years in practice. Based on federal Medicare data, Dr. Panthulu performed 286,977 Medicare services across 1,832 unique beneficiaries.

Between the years covered by Open Payments, Dr. Panthulu received a total of $24,131 from 43 pharmaceutical and/or device companies across 1050 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Panthulu is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice▲ Top 4% volume in FL$ $24,131 industry payments

Medicare Practice Summary

Medicare Utilization ↗
286,977
Medicare services
Top 4% in FL for rheumatology
1,832
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~17,936 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Certolizumab injection (Cimzia)165,600$4$16
Romosozumab injection (Evenity) for osteoporosis70,140$8$24
Golimumab infusion (Simponi Aria)16,573$10$60
Abatacept infusion (Orencia)15,725$34$100
Denosumab injection (Prolia/Xgeva)13,920$18$45
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle1,746$54$194
Office visit, established patient (30-39 min)1,198$90$273
Steroid injection (triamcinolone)636$1$15
Administration of chemotherapy into vein, 1 hour or less413$95$345
Injection, ketorolac tromethamine, per 15 mg202$0$5
New patient office visit (45-59 min)166$121$416
Drug injection, under skin or into muscle154$11$85
Injection, zoledronic acid, 1 mg135$6$50
Administration of chemotherapy into vein, each additional hour90$21$76
Office visit, established patient (20-29 min)65$68$187
Joint injection, major joint58$44$155
Injection of additional new drug or substance into vein51$12$42
Office visit, established patient, complex (40-54 min)32$134$367
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less27$44$176
Limited ultrasound scan of joint or other extremity structure except blood vessels16$34$143
Aspiration and/or injection of fluid from medium joint15$44$130
New patient office visit, complex (60-74 min)15$173$523
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
11.3% high complexity
88.2% medium
0.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$24,131
Total received (2018-2024)
Avg $3,447/year across 7 years
Top 20% in FL for rheumatology
43
Companies
1,050
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$22,228 (92.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,903 (7.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,611
2023
$3,800
2022
$4,100
2021
$3,278
2020
$3,263
2019
$3,597
2018
$1,483

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$5,607
Janssen Biotech, Inc.
$2,919
UCB, Inc.
$2,098
ABBVIE INC.
$1,949
PFIZER INC.
$1,719
Radius Health, Inc.
$1,060
Horizon Therapeutics plc
$915
Aurinia Pharma U.S., Inc.
$898
AbbVie Inc.
$771
GlaxoSmithKline, LLC.
$626
AbbVie, Inc.
$611
Janssen Scientific Affairs, LLC
$610
Novartis Pharmaceuticals Corporation
$582
GENZYME CORPORATION
$532
AstraZeneca Pharmaceuticals LP
$531
E.R. Squibb & Sons, L.L.C.
$437
Lilly USA, LLC
$408
Celgene Corporation
$299
Genentech USA, Inc.
$206
Boehringer Ingelheim Pharmaceuticals, Inc.
$197
Alexion Pharmaceuticals, Inc.
$150
Shire North American Group Inc
$145
Mallinckrodt Hospital Products Inc.
$134
Fresenius Kabi USA, LLC
$73
Organon LLC
$65
Ultragenyx Pharmaceutical Inc.
$62
ABIOMED
$60
SOBI, INC
$56
TerSera Therapeutics LLC
$50
FIDIA PHARMA USA INC.
$43
Sobi, Inc
$41
ANI Pharmaceuticals, Inc.
$33
Organon Llc
$32
Flexion Therapeutics, Inc.
$30
Antares Pharma, Inc.
$28
Kyowa Kirin, Inc.
$26
Sandoz Inc.
$22
SANOFI-AVENTIS U.S. LLC
$21
Horizon Pharma plc
$21
Pacira Pharmaceuticals Incorporated
$18
Kiniksa Pharmaceuticals International, plc
$17
Merck Sharp & Dohme Corporation
$16
Fidia Pharma USA Inc.
$13
Top 3 companies account for 44.0% of total payments
Associated products mentioned in payments ›
ACTHAR · Actemra · Arcalyst · BENLYSTA · Bimzelx · Briviact · CINRYZE · COSENTYX · CRYSVITA · CUVITRU · CYLTEZO · Cimzia · Crysvita · EVENITY · EVUSHELD · Enbrel · FORTEO · HADLIMA · HUMIRA · HYALGAN · HYM/HYN · HYRIMOZ · Humira · Hymovis · IDACIO · INFLECTRA · Impella · Iovera · KEVZARA · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · NEXPLANON · OFEV · ORENCIA · Otezla · Otrexup · PURIFIED CORTROPHIN GEL · Prolia · Quzyttir · RAYOS · REMICADE · RENFLEXIS · RINVOQ · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · SPEVIGO · STELARA · STRENSIQ · Strensiq · TALTZ · TAVNEOS · TREMFYA · Tavneos · Tymlos · UPLIZNA · XELJANZ · XYOSTED · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (92%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $8 per 100 Medicare services performed
Looking for a rheumatology in Sun City Center?
Compare rheumatologys in the Sun City Center area by procedure volume, costs, and industry payment transparency.
Browse rheumatologys nearby

Geographic Context

Rheumatologys within 10 mi
31
Per 100K population
2.1
County median income
$75,011
Nearest hospital
HCA FLORIDA SOUTH SHORE HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Panthulu is a mixed practice specialist, with above-average Medicare volume (top 4% in FL), and high industry engagement (low-engagement, top 20%), with 16 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Panthulu experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Panthulu performed 165,600 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Panthulu receive payments from pharmaceutical companies?
Yes. Dr. Panthulu received a total of $24,131 from 43 companies across 1,050 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Panthulu's costs compare to other rheumatologys in Sun City Center?
Dr. Panthulu's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Panthulu) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →